Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Gastrointest Endosc. Jan 16, 2018; 10(1): 16-22
Published online Jan 16, 2018. doi: 10.4253/wjge.v10.i1.16
Figure 1
Figure 1 Niti-S 14 appearance with a braided structure made from nitinol, and a large diameter of 14 mm with a length of 60 or 80 mm.
Figure 2
Figure 2 Stent placement of Niti-S 14 after sphincterotomy in pancreatic cancer. A: Endoscopic view; B: Picture of endoscopic retrograde pancreatocholangiography.
Figure 3
Figure 3 Endoscopic view of the duodenal major papilla after Niti-S 14 placement. The bile duct cavity is maintained despite bile duct mucosa or tumor growth into the stent.
Figure 4
Figure 4 Kaplan-Meier analysis of stent patency. The non-RBO rates of 3, 6 and 12 mo were 100%, 91% and 78%, respectively. RBO: Recurrent biliary obstruction.
Figure 5
Figure 5 Kaplan-Meier analysis of survival. The median survival time was 120 d.